Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.
Looking for information about blood clots, deep vein thrombosis and pulmonary embolisms? A new JGH website has the information you need.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.
Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.
People with chronic obstructive pulmonary disease (COPD) or pneumonia are more likely to die during a weekend stay in hospital, concludes a study conducted by Dr. Samy Suissa, Director of the Centre for Clinical Epidemiology in the Lady Davis Institute at the JGH.
Dr. Mark Eisenberg, a researcher at the Centre for Clinical Epidemiology in the Lady Davis Institute at the JGH, has received more than $800,000 to lead a randomized clinical trial to determine whether electronic cigarettes can help smokers kick the habit.